Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 14.95% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Consumer Staples | 10.7% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Global X SuperDividend REIT ETF
SRET
$230M
| $199K | ﹤0.01% |
+7,200
| New | +$196K |
|
|
PPBT
3652
Purple Biotech
PPBT
$2.41M
| $198K | ﹤0.01% |
+251
| New | +$162K |
|
3653
Solid Power
SLDP
$545M
| $198K | ﹤0.01% |
+22,800
| New | +$177K |
|
|
VBIO
3654
Valion Bio
VBIO
$709K
| $197K | ﹤0.01% |
+72
| New | +$235K |
|
3655
Yunhong Green CTI Ltd
YHGJ
$9.02M
| $197K | ﹤0.01% |
16,077
-3,550
| -18% | -$36.6K |
|
3656
Skillful Craftsman
EDTK
$14.6M
| $196K | ﹤0.01% |
156,500
+45,500
| +41% | +$59K |
|
3657
LG Display
LPL
$3.37B
| $196K | ﹤0.01% |
+23,755
| New | +$202K |
|
|
USER
3658
DELISTED
UserTesting, Inc.
USER
| $196K | ﹤0.01% |
+18,300
| New | +$152K |
|
3659
Xenetic Biosciences
XBIO
$7.56M
| $195K | ﹤0.01% |
19,141
-6,981
| -27% | -$72.8K |
|
3660
Inseego
INSG
$82.6M
| $193K | ﹤0.01% |
4,765
-6,506
| -58% | -$298K |
|
|
FTH
3661
Faeth Therapeutics
FTH
$759M
| $192K | ﹤0.01% |
+4,160
| New | +$331K |
|
3662
Protara Therapeutics
TARA
$233M
| $192K | ﹤0.01% |
37,600
-27,200
| -42% | -$143K |
|
|
ENFY
3663
DELISTED
Enlightify Inc
ENFY
| $192K | ﹤0.01% |
19,051
+7,700
| +68% | +$69.6K |
|
3664
Achieve Life Sciences
ACHV
$687M
| $191K | ﹤0.01% |
25,200
+1,400
| +6% | +$10.4K |
|
3665
TRX Gold Corp
TRX
$341M
| $189K | ﹤0.01% |
611,000
+467,274
| +325% | +$173K |
|
3666
UNIFI
UFI
$127M
| $187K | ﹤0.01% |
10,334
-27,200
| -72% | -$538K |
|
3667
iBio
IBIO
$73M
| $186K | ﹤0.01% |
+870
| New | +$182K |
|
3668
Lexicon Pharmaceuticals
LXRX
$1.04B
| $186K | ﹤0.01% |
+88,776
| New | +$246K |
|
3669
Tantech Holdings
TANH
$5.27M
| $185K | ﹤0.01% |
+405
| New | +$954K |
|
3670
Nuwellis
NUWE
$474K
| – | – |
0
| – | – |
|
|
TONX
3671
TON Strategy Co
TONX
$158M
| $184K | ﹤0.01% |
+24
| New | +$224K |
|
3672
Erasca
ERAS
$6.25B
| $182K | ﹤0.01% |
+21,200
| New | +$246K |
|
|
TTSH
3673
DELISTED
Tile Shop Holdings
TTSH
| $181K | ﹤0.01% |
27,600
+7,800
| +39% | +$51.2K |
|
|
SRGA
3674
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $181K | ﹤0.01% |
+19,792
| New | +$301K |
|
3675
Advantage Solutions
ADV
$399M
| $179K | ﹤0.01% |
+1,120
| New | +$194K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.